LW

Lars Wallentin

MH Medizinische Hochschule Hannover: 2 patents #28 of 182Top 20%
PH Pharmacia: 1 patents #80 of 319Top 30%
Overall (All Time): #1,442,557 of 4,157,543Top 35%
3
Patents All Time

Issued Patents All Time

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
11199552 Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof Kai C. Wollert, Tibor Kempf, Helmut Drexler 2021-12-14
8951742 Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof Kai C. Wollert, Tibor Kempf, Helmut Drexler 2015-02-10
6258798 Method for treatment of unstable coronary artery disease by an early revascularisation together with administration of a low molecular weight heparin 2001-07-10